Snippets from a fireside chat with our CCO, Abhijit Zutshi on #Collaboration, one of the behaviours that #Bioconites embrace and integrate into our daily practices. #CollaborationAtBiocon
About us
Biocon: Enhancing Global Healthcare Biocon Limited, publicly listed in 2004, is India's largest and fully-integrated, innovation-led biopharmaceutical company. It is an emerging global biopharmaceutical enterprise serving customers in over 120 countries. Driven by a vision to enhance global healthcare through innovative and affordable biopharmaceuticals, we have enabled access to advanced therapies for diseases that are chronic, where medical needs are largely unmet and treatment costs are high. The early anticipation of the increasing dominance of biologics in global development pipelines helped us to be ahead of the curve in crafting a differentiated product portfolio based on fermentation and recombinant technologies, which straddles fermentation-derived small molecules and biologics, both novel as well as biosimilars. The significant brand equity that we have built worldwide for our small molecule APIs across statins, immunosuppresants and other specialty products has made us a leading global supplier of these products. We have also built one of the largest and most diverse biosimilar pipelines, spanning insulins, monoclonal antibodies and other recombinant proteins that address critical chronic diseases such as diabetes, cancer and autoimmune disorders. Ranked among the Top 3 biosimilar players globally for rh-insulin and insulin glargine in volume terms, we are the first Indian company to launch a biosimilar in Japan with Insulin Glargine, which also has been approved for sale in EU and Australia. Our insulin products have made a difference to the lives of millions of people with diabetes across the globe. We now aim to provide our insulin products to ‘one in five’ people with diabetes in need of insulin-based therapy anywhere in the world within the next 10 years. We are also making a huge impact in the area of cancer care. Our biosimilar Trastuzumab, which was the first to be approved anywhere in the world and launched in India in 2014, has helped treat several thousand HER2-positive metastatic breast cancer patients. We are also the first company from India to get its biosimilar approved by the USFDA; Ogivri™, co-developed by Biocon and Mylan, is the first biosimilar Trastuzumab to be approved in the US. In addition to Trastuzumab, several of our biosimilar assets are on track for anticipated regulatory approvals in developed markets. We are also developing a pipeline of patented biologics to address global unmet medical needs. We have successfully launched a couple of novel biologics in India: Nimotuzumab for the treatment of head and neck cancer and Itolizumab to tackle psoriasis. Besides these, we have a basket of novel assets are under various stages of clinical development, including a high potential oral insulin. Through our subsidiary, Syngene, we offer a suite of integrated, end-to-end discovery and development services for novel molecular entities (NMEs) to the global life sciences sector. Ranked by the prestigious Science magazine among the Top 10 Best employers in the biotech industry, Biocon is passionately pursuing a mission to rationalize healthcare spends, enhance access to life-saving therapies and make a significant impact to global healthcare through ‘blockbuster’ drugs with the potential to benefit a billion patients.
- Website
-
http://www.biocon.com
External link for Biocon
- Industry
- Biotechnology Research
- Company size
- 5,001-10,000 employees
- Headquarters
- Bangalore, Karnataka
- Type
- Public Company
Locations
-
Primary
Hosur Road, Electronics City
Bangalore, Karnataka 560100, IN
Employees at Biocon
Updates
-
Snippets from a fireside chat with our CSO, Manoj Kumar Pananchukunnath on #ThinkingOutOfTheBox, a behaviour that Bioconites have adopted and practice each day as we think creatively, challenge assumptions and look beyond traditional approaches to come up with innovative healthcare solutions. #Biocon
-
#Biocon will be at #CPHIMilan! We are excited to be at CPHI Milan and look forward to meeting our customers and partners to share our latest product developments and services with them. To book a meeting write to us at: For API: [email protected]; For Generic formulations: [email protected]
-
#WelcomeToBiocon: Always excited to welcome new #Bioconites to the team! Congratulations, and we look forward to you contributing to our purpose of providing everyone, everywhere, affordable access to medicines. #Biocon
-
Biocon reposted this
Learn from the best minds in the Biotech industry! If you are ready to make your mark, here’s your moment—applications for Batch 28 of the Biocon KGI Certificate in Biosciences are NOW OPEN! 🎯 What’s in it for you? 👉 Direct interactions with renowned experts from academia, Biocon, and the biotech industry 👉 Mentorship by industry leaders and experienced faculty from KGI and Biocon Academy 👉 Functional visits to Biocon facilities, along with hands-on training sessions by Biozeen and Thermo Fisher Scientific 👉 Professional development and personal grooming sessions led by our in-house experts 👉 Job-ready skills with 100% placement assistance Apply Today: https://bit.ly/BA-B28 #admissions #biosciences #biotechnology #careers #freshers #opportunities #science #stem #technology
-
Biocon Limited has partnered with Ministry of Skill Development and Entrepreneurship (MSDE) to hire freshers as apprentices under National #Apprenticeship Promotion Scheme (NAPS). Selected candidates will receive extensive on the job training for 6 to 12 months, which may be followed by full time employment #opportunity in Bengaluru based on available vacancies at the time. If you are interested in this opportunity, walk-in for an interview at #Kolar on Sunday, 1st September, in collaboration with #MSDESkillIndia.
-
This #NationalSportsDay, let’s recognize the incredible benefits of sports for both body and mind. Every game, run, or workout helps us stay healthy and strong. Keep active, keep thriving!
-
Biocon Limited has partnered with Ministry of Skill Development and Entrepreneurship (MSDE) to hire freshers as apprentices under National Apprenticeship Promotion Scheme (NAPS). Selected candidates will receive extensive on the job training for 6 to 12 months, which may be followed by full time employment opportunity in Bengaluru based on available vacancies at the time. If you are interested in this opportunity, walk-in for an interview at #Kolar on Sunday, 1st September, in collaboration with #MSDESkillIndia.
-
"By prioritizing value over volume, India’s pharmaceutical industry can become a world leader in high-value exports and nearly triple its revenue by 2030, significantly impacting global healthcare." Kiran Mazumdar Shaw in this article highlights the role India can play in global #healthcare. Read the article here: https://lnkd.in/ecRT26Bm
-
Understanding menopause helps in recognizing and managing its physical and emotional impact. Increased awareness also empowers individuals to seek appropriate support. Recently, Dr. Anu Joseph, Senior Consultant – Obstetrics, Gynecology and Fetal Medicine, led Bioconites through a healthcare session that explored coping mechanisms and health risks associated with menopause.